Ivarest Poison Ivy Removal and Itch Relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Ivarest Poison Ivy Removal and Itch Relief
Generic name: PRAMOXINE HYDROCHLORIDE
Manufacturer: Blistex Inc.
Product type: HUMAN OTC DRUG
SPL set ID: dedbf5d9-0f86-4f32-8321-da86c9838c0a
SPL ID: 61e42ae1-bdd5-43fb-a98e-3d28f0651074
Version: 1
Effective date: 2025-04-29
Source export date: 2026-10-12
Source partition: 6
Source file: https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/b25dad4aaef9c88f0e827394a34fbbd1ce7d71422fa46b5d1e123befad498c1d/drug-label-0006-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:47:36

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Ivarest Poison Ivy Removal and Itch Relief	openfda.brand_name
generic name		PRAMOXINE HYDROCHLORIDE	openfda.generic_name
manufacturer name		Blistex Inc.	openfda.manufacturer_name
ndc	package	10157-2125-1	openfda.package_ndc
ndc	product	10157-2125	openfda.product_ndc
ndc11	package	10157212501	derived:openfda.package_ndc
spl id		61e42ae1-bdd5-43fb-a98e-3d28f0651074	id
spl set id		dedbf5d9-0f86-4f32-8321-da86c9838c0a	set_id
unii		88AYB867L5	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only When using this product avoid contact with the eyes If condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult a doctor. Keep out of reach of children.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.